(NASDAQ: AHCO) Adapthealth's forecast annual revenue growth rate of 5.96% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.3%.
Adapthealth's revenue in 2024 is $3,200,177,000.On average, 5 Wall Street analysts forecast AHCO's revenue for 2024 to be $441,760,483,257, with the lowest AHCO revenue forecast at $438,659,893,452, and the highest AHCO revenue forecast at $445,690,014,665. On average, 5 Wall Street analysts forecast AHCO's revenue for 2025 to be $471,888,928,622, with the lowest AHCO revenue forecast at $463,266,314,501, and the highest AHCO revenue forecast at $487,051,369,654.
In 2026, AHCO is forecast to generate $523,157,311,976 in revenue, with the lowest revenue forecast at $493,726,894,716 and the highest revenue forecast at $552,587,862,143.